Patents by Inventor Thomas H. Scholz

Thomas H. Scholz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucosyltransferase enzymes for production of glucan polymers
    Patent number: 10793838
    Abstract: Compositions are disclosed herein comprising poly alpha-1,3-1,6-glucan with a weight average degree of polymerization (DPw) of at least 1000. This glucan polymer comprises at least 30% alpha-1,3 linkages and at least 30% alpha-1,6 linkages. Further disclosed are glucosyltransferase enzymes that synthesize poly alpha-1,3-1,6-glucan. Ether derivatives of poly alpha-1,3-1,6-glucan and methods of using such derivatives as viscosity modifiers are also disclosed.
    Type: Grant
    Filed: April 12, 2019
    Date of Patent: October 6, 2020
    Assignee: DUPONT INDUSTRIAL BIOSCIENCES USA, LLC
    Inventors: Jayme L. Paullin, Mark S. Payne, T. Joseph Dennes, Yefim Brun, Rakesh Nambiar, Thomas H. Scholz
  • GLUCOSYLTRANSFERASE ENZYMES FOR PRODUCTION OF GLUCAN POLYMERS
    Publication number: 20190270973
    Abstract: Compositions are disclosed herein comprising poly alpha-1,3-1,6-glucan with a weight average degree of polymerization (DPw) of at least 1000. This glucan polymer comprises at least 30% alpha-1,3 linkages and at least 30% alpha-1,6 linkages. Further disclosed are glucosyltransferase enzymes that synthesize poly alpha-1,3-1,6-glucan. Ether derivatives of poly alpha-1,3-1,6-glucan and methods of using such derivatives as viscosity modifiers are also disclosed.
    Type: Application
    Filed: April 12, 2019
    Publication date: September 5, 2019
    Inventors: Jayme L. Paullin, Mark S. Payne, T. Joseph Dennes, Yefim Brun, Rakesh Nambiar, Thomas H. Scholz
  • Glucosyltransferase enzymes for production of glucan polymers
    Patent number: 10260053
    Abstract: Compositions are disclosed herein comprising poly alpha-1,3-1,6-glucan with a weight average degree of polymerization (DPw) of at least 1000. This glucan polymer comprises at least 30% alpha-1,3 linkages and at least 30% alpha-1,6 linkages. Further disclosed are glucosyltransferase enzymes that synthesize poly alpha-1,3-1,6-glucan. Ether derivatives of poly alpha-1,3-1,6-glucan and methods of using such derivatives as viscosity modifiers are also disclosed.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: April 16, 2019
    Assignee: E I DU PONT DE NEMOURS AND COMPANY
    Inventors: Jayme L. Paullin, Mark S. Payne, T. Joseph Dennes, Yefim Brun, Rakesh Nambiar, Thomas H Scholz
  • GLUCOSYLTRANSFERASE ENZYMES FOR PRODUCTION OF GLUCAN POLYMERS
    Publication number: 20180273919
    Abstract: Compositions are disclosed herein comprising poly alpha-1,3-1,6-glucan with a weight average degree of polymerization (DPw) of at least 1000. This glucan polymer comprises at least 30% alpha-1,3 linkages and at least 30% alpha-1,6 linkages. Further disclosed are glucosyltransferase enzymes that synthesize poly alpha-1,3-1,6-glucan. Ether derivatives of poly alpha-1,3-1,6-glucan and methods of using such derivatives as viscosity modifiers are also disclosed.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 27, 2018
    Inventors: JAYME L PAULLIN, MARK S. PAYNE, T. JOSEPH DENNES, YEFIM BRUN, RAKESH NAMBIAR, THOMAS H SCHOLZ
  • Intermediates for preparing HMG-CoA reductase inhibitors
    Patent number: 4874870
    Abstract: A process for converting 6-carboxy to 6-hydroxymethyl mevinolin analogs and novel intermediates formed in this process are disclosed.
    Type: Grant
    Filed: August 12, 1988
    Date of Patent: October 17, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Samuel L. Graham, Thomas H. Scholz
  • Alkanesulfonamides as antiglaucoma agents
    Patent number: 4812463
    Abstract: Alkane sulfonamides with an electron withdrawing function .beta. to the sulfonamide group are topically effective carbonic anhydrase inhibitors useful in the treatment of elevated intraocular pressure and glaucoma.
    Type: Grant
    Filed: December 10, 1987
    Date of Patent: March 14, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Samuel L. Graham, Thomas H. Scholz
  • Intermediates for preparing HMG-CoA reductase inhibitors
    Patent number: 4795811
    Abstract: A process for converting 6-carboxy to 6-hydroxymethyl mevinolin analogs and novel intermediates formed in this process are disclosed.
    Type: Grant
    Filed: June 22, 1987
    Date of Patent: January 3, 1989
    Assignee: Merck & Co., Inc.
    Inventors: Samuel L. Graham, Thomas H. Scholz
  • 1-Aryl-4-hydrazinyl-s-triazin-2-ones
    Patent number: 4460585
    Type: Grant
    Filed: January 17, 1983
    Date of Patent: July 17, 1984
    Assignee: William H. Rorer, Inc.
    Inventors: Henry F. Campbell, Thomas H. Scholz, George H. Douglas
  • 6-Aryl-4-hydrazinyl-s-triazin-2-ones
    Patent number: 4406897
    Type: Grant
    Filed: July 6, 1981
    Date of Patent: September 27, 1983
    Assignee: William H. Rorer, Inc.
    Inventors: Henry F. Campbell, Thomas H. Scholz, George H. Douglas